BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23296939)

  • 1. Mannosylated and histidylated LPR technology for vaccination with tumor antigen mRNA.
    Pichon C; Midoux P
    Methods Mol Biol; 2013; 969():247-74. PubMed ID: 23296939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA.
    Perche F; Benvegnu T; Berchel M; Lebegue L; Pichon C; Jaffrès PA; Midoux P
    Nanomedicine; 2011 Aug; 7(4):445-53. PubMed ID: 21220051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA-based cancer vaccine: prevention of B16 melanoma progression and metastasis by systemic injection of MART1 mRNA histidylated lipopolyplexes.
    Mockey M; Bourseau E; Chandrashekhar V; Chaudhuri A; Lafosse S; Le Cam E; Quesniaux VF; Ryffel B; Pichon C; Midoux P
    Cancer Gene Ther; 2007 Sep; 14(9):802-14. PubMed ID: 17589432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients.
    Bonehill A; Van Nuffel AM; Corthals J; Tuyaerts S; Heirman C; François V; Colau D; van der Bruggen P; Neyns B; Thielemans K
    Clin Cancer Res; 2009 May; 15(10):3366-75. PubMed ID: 19417017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration.
    Hattori Y; Kawakami S; Lu Y; Nakamura K; Yamashita F; Hashida M
    J Gene Med; 2006 Jul; 8(7):824-34. PubMed ID: 16625665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective gene delivery in dendritic cells with mannosylated and histidylated lipopolyplexes.
    Perche F; Gosset D; Mével M; Miramon ML; Yaouanc JJ; Pichon C; Benvegnu T; Jaffrès PA; Midoux P
    J Drug Target; 2011 Jun; 19(5):315-25. PubMed ID: 20653408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicomponent mannose-containing liposomes efficiently deliver RNA in murine immature dendritic cells and provide productive anti-tumour response in murine melanoma model.
    Markov OV; Mironova NL; Shmendel EV; Serikov RN; Morozova NG; Maslov MA; Vlassov VV; Zenkova MA
    J Control Release; 2015 Sep; 213():45-56. PubMed ID: 26134071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical evaluation of mRNA trimannosylated lipopolyplexes as therapeutic cancer vaccines targeting dendritic cells.
    Le Moignic A; Malard V; Benvegnu T; Lemiègre L; Berchel M; Jaffrès PA; Baillou C; Delost M; Macedo R; Rochefort J; Lescaille G; Pichon C; Lemoine FM; Midoux P; Mateo V
    J Control Release; 2018 May; 278():110-121. PubMed ID: 29630987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-lasting dendritic cell DNA vaccination system using lysinylated amphiphiles with mannose-mimicking head-groups.
    Srinivas R; Garu A; Moku G; Agawane SB; Chaudhuri A
    Biomaterials; 2012 Sep; 33(26):6220-9. PubMed ID: 22658799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor vaccination with synthetic mRNA: strategies for in vitro and in vivo preclinical studies.
    Diken M; Kreiter S; Selmi A; Türeci O; Sahin U
    Methods Mol Biol; 2013; 969():235-46. PubMed ID: 23296938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of tumor-antigen-encoding mRNA into dendritic cells for vaccination.
    Michiels A; Tuyaerts S; Bonehill A; Heirman C; Corthals J; Thielemans K
    Methods Mol Biol; 2008; 423():155-63. PubMed ID: 18370196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Enhanced translational efficacy of internal ribosomal entry site-mediated mRNA in dendritic cells contributes to efficient induction of antitumor immunity].
    Tan XH; Wan YH
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):399-403. PubMed ID: 17456382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice.
    Hattori Y; Kawakami S; Suzuki S; Yamashita F; Hashida M
    Biochem Biophys Res Commun; 2004 May; 317(4):992-9. PubMed ID: 15094367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel cationic liposomes provide highly efficient delivery of DNA and RNA into dendritic cell progenitors and their immature offsets.
    Markov OO; Mironova NL; Maslov MA; Petukhov IA; Morozova NG; Vlassov VV; Zenkova MA
    J Control Release; 2012 Jun; 160(2):200-10. PubMed ID: 22155599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient gene transfer into macrophages and dendritic cells by in vivo gene delivery with mannosylated lipoplex via the intraperitoneal route.
    Hattori Y; Kawakami S; Nakamura K; Yamashita F; Hashida M
    J Pharmacol Exp Ther; 2006 Aug; 318(2):828-34. PubMed ID: 16670348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an antigen-presenting cell-targeted DNA vaccine against melanoma by mannosylated liposomes.
    Lu Y; Kawakami S; Yamashita F; Hashida M
    Biomaterials; 2007 Jul; 28(21):3255-62. PubMed ID: 17449093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of cancer with dendritic cells loaded with tumor antigens and activated through mRNA electroporation.
    Van Nuffel AM; Corthals J; Neyns B; Heirman C; Thielemans K; Bonehill A
    Methods Mol Biol; 2010; 629():405-52. PubMed ID: 20387165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with messenger RNA.
    Pascolo S
    Methods Mol Med; 2006; 127():23-40. PubMed ID: 16988444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic delivery of complexes of melanoma RNA with mannosylated liposomes activates highly efficient murine melanoma-specific cytotoxic T cells in vivo].
    Markov OV; Mironova NL; Shmendel EV; Maslov MA; Zenkova MA
    Mol Biol (Mosk); 2017; 51(1):118-125. PubMed ID: 28251974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ expression of tumor antigens by messenger RNA-electroporated dendritic cells in lymph nodes of melanoma patients.
    Schuurhuis DH; Verdijk P; Schreibelt G; Aarntzen EH; Scharenborg N; de Boer A; van de Rakt MW; Kerkhoff M; Gerritsen MJ; Eijckeler F; Bonenkamp JJ; Blokx W; van Krieken JH; Boerman OC; Oyen WJ; Punt CJ; Figdor CG; Adema GJ; de Vries IJ
    Cancer Res; 2009 Apr; 69(7):2927-34. PubMed ID: 19318559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.